Literature DB >> 6092538

Hormonal regulation of adipose S-100 protein release.

F Suzuki, K Kato, T Nakajima.   

Abstract

The release of S-100 protein from epididymal fat pads was enhanced by epinephrine in vitro, and about 50% of S-100 protein in the tissue was released into the medium after 2-h incubation at 37 degrees C with 10 microM epinephrine. Similar results were obtained with the incubation of isolated adipocytes. The S-100 protein release was also enhanced by isoproterenol, norepinephrine, ACTH, and dibutyryl cyclic AMP, which all increase the lipolysis by increasing cyclic AMP levels in the tissue. Propranolol, a beta-adrenergic blocker, could block the increase of S-100 protein release by catecholamines, indicating that the release was mediated by the beta-adrenergic effect of catecholamines. However propranolol had no suppressive effect on the enhancement of S-100 protein release by ACTH or dibutyryl cyclic AMP. Insulin had an inhibitory effect on the epinephrine-enhanced S-100 protein release. Epinephrine or ACTH could not stimulate the S-100 protein release in the absence of Ca2+, whereas the epinephrine-enhanced glycerol release was not affected under the same conditions. The increase in S-100 protein release was induced by only a pretreatment of the tissue with epinephrine. However, the lipolysis in the tissue was not enhanced by the pretreatment alone. These results indicate that the release of S-100 protein from adipocytes is regulated by the hormones that have been known to control the lipolysis with a manner slightly different from that of lipolysis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092538     DOI: 10.1111/j.1471-4159.1984.tb05391.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

Review 1.  S100B as a marker for brain damage and blood-brain barrier disruption following exercise.

Authors:  Serene X T Koh; Jason K W Lee
Journal:  Sports Med       Date:  2014-03       Impact factor: 11.136

2.  The ultrastructural changes of S-100 protein localization during lipolysis in adipocytes. An immunoelectron-microscopic study.

Authors:  H Haimoto; K Kato; F Suzuki; H Nagura
Journal:  Am J Pathol       Date:  1985-11       Impact factor: 4.307

3.  Elevated concentrations of the beta-subunit of S100 protein in renal cell tumors in rats.

Authors:  M Takashi; T Sakata; Y Nakano; Y Yamada; K Miyake; K Kato
Journal:  Urol Res       Date:  1994

4.  S100B Serum Levels in Schizophrenia Are Presumably Related to Visceral Obesity and Insulin Resistance.

Authors:  Johann Steiner; Aye Mu Myint; Kolja Schiltz; Sabine Westphal; Hans-Gert Bernstein; Martin Walter; Matthias L Schroeter; Markus J Schwarz; Bernhard Bogerts
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-10

5.  S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond.

Authors:  Guglielmo Sorci; Roberta Bianchi; Francesca Riuzzi; Claudia Tubaro; Cataldo Arcuri; Ileana Giambanco; Rosario Donato
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-18

6.  S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner.

Authors:  Guglielmo Sorci; Francesca Riuzzi; Anna Lisa Agneletti; Cristina Marchetti; Rosario Donato
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

7.  Adipocytes as an Important Source of Serum S100B and Possible Roles of This Protein in Adipose Tissue.

Authors:  Carlos Alberto Gonçalves; Marina Concli Leite; Maria Cristina Guerra
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-06-28

8.  Serum S100B levels after meningioma surgery: A comparison of two laboratory assays.

Authors:  Eyal Itshayek; Jeremy D Kark; Haim Ovadia; Carolyn F Weiniger; Yigal Shoshan; Sharon Einav
Journal:  BMC Clin Pathol       Date:  2008-09-19

9.  Early postoperative serum S100 beta levels predict ongoing brain damage after meningioma surgery: a prospective observational study.

Authors:  Sharon Einav; Yigal Shoshan; Haim Ovadia; Idit Matot; Moshe Hersch; Eyal Itshayek
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.